Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain; Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain; Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain; Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain; Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain; Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain; fatigue; headache; muscle pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 06Aug2021 12:00 (Lot number: EW0171) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st, Date: 16Jul2021 , Time (24hr): 11:00 (Approx 11:00 AM), Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: ER8731, Pertinent details: Felt like needle was still in arm. Felt like heavy ball in arm, redness, warmth, mild swelling, firmness, itching, pain, fatigue headache, muscle pain, dizziness, short of breath.), administration date: 16Jul2021, for covid-19 immunisation, reaction(s): "firmness", "Heavy ball in my arm", "short of breath", "Needle was still in my arm", "dizzy", "redness", "warmth", "mild swelling", "itching", "pain", "headache", "muscle pain". The following information was reported: VACCINATION SITE PRURITUS (non-serious), VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE WARMTH (non-serious), VACCINATION SITE INDURATION (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 06Aug2021 12:00, outcome "not recovered" and all described as "Injection site reaction: Redness, warmth, mild swelling, firmness, itching, pain"; FATIGUE (non-serious) with onset 06Aug2021 12:00, outcome "not recovered", described as "fatigue"; HEADACHE (non-serious) with onset 06Aug2021 12:00, outcome "not recovered", described as "headache"; MYALGIA (non-serious) with onset 06Aug2021 12:00, outcome "not recovered", described as "muscle pain". The event "injection site reaction: redness, warmth, mild swelling, firmness, itching, pain", "injection site reaction: redness, warmth, mild swelling, firmness, itching, pain", "injection site reaction: redness, warmth, mild swelling, firmness, itching, pain" and "injection site reaction: redness, warmth, mild swelling, firmness, itching, pain" was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of vaccination site pruritus, vaccination site erythema, vaccination site warmth, vaccination site induration, vaccination site swelling, vaccination site pain, fatigue, headache, myalgia.  Additional information: it was unknown if the event require the initiation of new medication/ other treatment / procedure. Concomitant drugs were unknown.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100912041 same reporter/patient/product, different dose and similar events.